Mendel Goldfinger
ScholarGPS® ID: 77966740662232
Affiliation History
Field
Medicine
Discipline
Oncology
Top Specialties
Lymphoma | Cancer | COVID-19 | Leukemia | B-cell Lymphoma | Cell Therapy | Endometrial Cancer | Hematopoietic Stem Cell
Metrics Summary
Publication Count
72
Predicted Citations
1,446
Predicted h-index
11
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Myelofibrosis prognostic models validated in an underserved minority population: A retrospective analysis. (journal article) Journal of Clinical Oncology, volume 42, issue 16_suppl, pages e18529-e18529 (2024). |
Improving Unrelated Donor Equity: Assessing Mismatched Donor Opportunities with Real-World Data in a Minority-Predominant Cohort (journal article) Transplantation and Cellular Therapy, volume 30, issue 5, pages 544.e1-544.e8 (2024). |
Transplantation and Cellular Therapy, volume 30, issue 2, pages S321- (2024). |
Improving Allogenic Hematopoietic Stem Cell Transplantation Equity: Assessing Mismatched Donor Opportunities with Real World Data in a Minority-Rich Cohort (journal article) Transplantation and Cellular Therapy, volume 30, issue 2, pages S320- (2024). |
Acta Oncologica, volume 62, issue 12, pages 1956-1960 (2023). |
Blood, volume 142, issue Supplement 1, pages 2968-2968 (2023). |
High PD-L1 Expression May be Associated with Worse Overall Prognosis in Acute Myeloid Leukemia (journal article) Blood, volume 142, issue Supplement 1, pages 6050-6050 (2023). |
A Study Evaluating Financial Toxicity Amongst Hematologic Malignancy Patients in the Bronx (journal article) Blood, volume 142, issue Supplement 1, pages 7397-7397 (2023). |
Blood, volume 142, issue Supplement 1, pages 4257-4257 (2023). |
Transportation Cost Is a Significant Barrier to Quality Care for Hematologic Malignancy Patients in a Minority-Rich, Socioeconomically Disadvantaged Population (journal article) Blood, volume 142, issue Supplement 1, pages 2350-2350 (2023). |
JCO Oncology Practice, volume 19, issue 11_suppl, pages 390-390 (2023). |
MM-413 Early Mortality in Multiple Myeloma- a SEER Data Analysis (journal article) Clinical Lymphoma Myeloma and Leukemia, volume 23 (2023). |
ALL-040 Hispanic Patients With T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Had Worse Overall Survival in a Minority Predominant Cohort (journal article) Clinical Lymphoma Myeloma and Leukemia, volume 23 (2023). |
Acute myeloid leukemias with JAK2/STAT mutations are associated with PD-L1 upregulation (journal article) Leukemia & Lymphoma, volume 64, issue 10, pages 1662-1672 (2023). |
A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML (journal article) Clinical Cancer Research, volume 29, issue 15, pages 2774-2780 (2023). |
Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma (journal article) Blood Advances, volume 7, issue 14, pages 3760-3763 (2023). |
Journal of Clinical Oncology, volume 41, issue 16_suppl, pages e19014-e19014 (2023). |
Association of ethnicity with overall survival in patients with T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma (journal article) Journal of Clinical Oncology, volume 41, issue 16_suppl, pages e18557-e18557 (2023). |
Chimeric Antigen Receptor T-Cell Therapy for Patients With Multiple Myeloma—A Call for Equal Opportunity (journal article) JAMA Oncology, volume 9, issue 3, pages 297- (2023). |
Transplantation and Cellular Therapy, volume 29, issue 2, pages S347-S348 (2023). |